Navigation Links
Systech International Announces its 150th Serialization Line
Date:2/25/2009

rnational customers. Systech has over 20 professional staff in Europe to meet the growing demands of the market.

Systech's suite of configurable software is based on a PES approach which enables bi-directional communication between packaging and IT environments. A PES architecture provides the new technology layer that is critical to the successful execution of emerging worldwide initiatives such as serialization. Systech's PES protects enterprise data integrity and package throughput.

About Systech International

Systech International is an innovator of packaging execution systems (PES) for the pharmaceutical industry. Systech offers a suite of productized software that quickly gives manufactures complete control over packaging processes along with the actionable intelligence required to continuously improve performance. Systech implements vision, line management, performance metric and serialization solutions for companies around the world to secure the supply chain and to optimize packing efficiencies. By partnering with Systech, companies can leverage a scaleable, repeatable architecture, to consistently deliver significant improvements at the machine, line and plant levels. For more information about their company and products, please visit www.systech-tips.com.

CONTACT: Frederic Menardo of Systech International Brussels Headquarters, +32-2-467-03-30; or Christian Barbato of Garfield Group Public Relations for Systech International, +1-215-867-8600, ext. 227, cbarbato@garfieldgroup.com


'/>"/>
SOURCE Systech International
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Purdue Pharma Selects Systech to Provide Sustainable Infrastructure for Serialization
2. Systech Augments Key Departments to Drive Operational Excellence and International Support
3. Systech Unveils Complete Packaging Execution System at Pack Expo 2008
4. International study strengthens case for daily calcium pill
5. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
6. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
7. LCA Hails International Investigators Studying Lung Cancer
8. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
9. PRA International Adds Dr. Susan Stansfield as Executive Vice President
10. Medical Services International Maintains Pace in Second Quarter
11. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: O...oreventsinDecember: ,, ASHBriefing ,, ...cipalinvestigatorswilldiscussdatapresentationssurr...lemyeloma,asfeaturedatthe51stAmericanSocietyofHema...LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a.m...
(Date:11/25/2009)...swire/--TheBlackAIDSInstituterecentlyheldBoardofDi...10. ,, ThenewBoardMembersareahighlydiversegroup...,governmenthealthprograms,editorial,andbusinessent...sonalbackgroundsincludingbothheterosexualandgayBla...sentingmultipleagegroups. ,, (Photo: http://www...
(Date:11/25/2009)...f a collaboration between UCLA engineers and physi...0 million Americans who suffer from peripheral art...the arteries, peripheral arterial disease, or PAD,... arteries reduce blood flow to the limbs. The cond...e, heart attack and stroke, and its progression ca...
(Date:11/25/2009)...to overlook needed care, study finds , ,... depression can worsen her child,s asthma, U.S. re...f 262 black mothers and their children found that ...s had more frequent asthma symptoms, while childre...ss frequent asthma symptoms. , The Johns Hopkin...
(Date:11/25/2009)...traightYear ,, WASHINGTON,Nov.25/PRNewswire-U...-GA)issuedthe 4thAnnualReportCardonLungCancer .Thi...slethaldiseaseinthestateofGeorgia.LCA-GAisachapter...iondedicatedexclusivelytopatientsupportandadvocacy...ogo: http://www.newscom.com/cgi-bin/prnh/20081016/...
Breaking Medicine News(10 mins):Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2
... "I worked for General,Shinseki when he was Army ...nd. He is a soldier who has dedicated his life to...en, he knows large organizations, and he knows,Was...ight years, they,deliver outstanding care. Genera...
.... 7 Results of the Phase 2,clinical trial of R788... or,refractory B-Cell non-Hodgkin,s lymphoma (NHL)...ng the 50th Annual American Society of Hematology ...it in,patients suffering from diffuse large B-Cell...
... December 7, 2008) Two studies examining the effe...ll transplantation outcomes will be explored at a ...7, at 8:00 a.m., during the 50th Annual Meeting of...ce of stem cells in cord blood for transplantation...
... Contract negotiations between,the Ohio Nurses Ass...ical,Center (University Hospitals Geneva) broke do..., December 5. To date, the parties have been unabl...va has indicated that they will,remove premium rat...
...st obesity, Americans need to re-learn proper serv...ealthDay News) -- All-you-can-eat buffets, super-s... wallet full, but they,re also helping to expand y...recognizing reasonable portion sizes anymore. , "...
... Klever Innovations has patented a new box...er or damage contents.This revolutionary new tool ...used in the 911 terrorist attacks. Tha Klever Kutt...ol is simple in design, lightweight, and easy to u...
Other Medicine News:Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 2Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 3Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 2Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 3Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 5Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 6Health News:University Hospitals Geneva Medical Center Registered Nurses to Strike on December 10 if Contract Agreement Cannot Be Reached 2Health News:Portion Distortion 2Health News:Portion Distortion 3Health News:Revolutionary New Safety Cutter Patented After 911 Terrorist Attacks Is Changing the Way Boxes Are Opened 2
(Date:11/25/2009)... ,, PRINCETON,N.J.,Nov.25/PRNewswire-FirstCa...pharmaceuticalcompanycommittedtodiscovering,develo...ions,reportedfinancialresultsforthefiscalyearended...58.4millionincash,cashequivalentsandshortterminves..., RG7128 ,, Phase2bTrial ,, InlateNo...
(Date:11/25/2009)... ,, WESTPALMBEACH,Fla.,Nov.25/PRNewswire-Fir...icans,especiallythe27millionlivingwithuntreated he...iologistCindyBeyer. ,, Dr.Beyer,seniorvicepresi...ringcareand hearingaids companies,saidstudieshavel...ation,"whichcaneasilybeintensifiedatholidaygatheri...
(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, UnitedStatesDentalDevices...w.reportlinker.com/p0158733/United-States-Dental-D... ,, UnitedStatesDentalDevicesMarketAnalysisandF...nessentialsourceforin-depthinformationanddatarelat...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 2Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 3Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 4Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 5Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 6Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 7Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 8Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 9Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 10Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 11Reportlinker Adds United States Dental Devices Market Analysis and Forecasts to 2015 12New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 1New Editor Named for International Journal Of Nursing Terminologies 26amp 3B Classifications 59323 2Capital BlueCross Reaches Out to Former Employees of Turbine Airfoil Designs 59319 1Capital BlueCross Reaches Out to Former Employees of Turbine Airfoil Designs 59319 2Blue Cross Names Three New Executives 59315 1Blue Cross Names Three New Executives 59315 2Blue Cross Names Three New Executives 59315 3
...III study will evaluate effects of otelixizumab, a...n preservation of endogenous insulin ...il 9, 2008 /PRNewswire/ - Tolerx, Inc., a,biopharm...elopment of novel,therapies for immune-mediated di...rd the initiation of a Phase III study of otelixiz...
...LANTA, April 9, 2008 Dutch biotechnology,company ...on and the South,African Tuberculosis Vaccine Init...ology data from a Phase I Ad35 tuberculosis vaccin... the World" conference (Atlanta,Georgia, April 9 t...uth,Africa and launched in May 2007, is the second...
Other Medicine Technology:Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 2Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 3Tolerx Advancing Novel Type 1 Diabetes Agent into Phase III Clinical Trial Program Following End of Phase II FDA Meeting 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 2Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 3Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 4Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 5Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa 6
The Carpal Solution
...mometer that measures temperatures from -50 to 200...splay and minimum/maximum temperature memory. The ...ally, with adhesive, by keyhole or flip-out desk s...accurate to within 1C from -50 to 120C and within ...
...ic pipets without purchasing equipment or interrup...ix vials of Receiver Solution and one or two vial(...or to be verified, the technologist performs six s...ck for analysis and calculation of the results. Wi...
...a sheath fluid when performing analysis by flow cy... dilutes to 3L of sheath fluid with distilled wate...ntrate reduces heavy lifting, increases usable spa...e. Streck Cytometry Concentrate has a closed-vial ...
Medicine Products: